B. Riley Wealth Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-16,727
Closed -$1.66M 926
2019
Q3
$1.66M Sell
16,727
-16
-0.1% -$1.52K 0.16% 140
2019
Q2
$1.55M Buy
16,743
+254
+2% +$24.1K 0.17% 126
2019
Q1
$1.56M Sell
16,489
-13,074
-44% -$1.14M 0.19% 108
2018
Q4
$1.9M Sell
29,563
-207
-0.7% -$15.3K 0.27% 83
2018
Q3
$2.67M Buy
29,770
+293
+1% +$25.9K 0.32% 66
2018
Q2
$2.34M Sell
29,477
-700
-2% -$58.1K 0.31% 69
2018
Q1
$2.69M Buy
30,177
+3,892
+15% +$374K 0.38% 65
2017
Q4
$2.74M Buy
26,285
+6,838
+35% +$772K 0.37% 68
2017
Q3
$2.84M Buy
19,447
+332
+2% +$45.2K 0.47% 47
2017
Q2
$2.48M Buy
19,115
+3,549
+23% +$435K 0.45% 53
2017
Q1
$1.94M Buy
15,566
+656
+4% +$78.5K 0.39% 64
2016
Q4
$1.73M Sell
14,910
-4,401
-23% -$490K 0.35% 77
2016
Q3
$1.59M Sell
19,311
-2,038
-10% -$221K 0.31% 77
2016
Q2
$1.7M Buy
21,349
+3,558
+20% +$368K 0.34% 61
2016
Q1
$1.37M Sell
17,791
-581
-3% -$59.8K 0.32% 79
2015
Q4
$2.2M Buy
18,372
+5,214
+40% +$603K 0.45% 53
2015
Q3
$1.42M Sell
13,158
-1,559
-11% -$193K 0.34% 67
2015
Q2
$1.71M Sell
14,717
-50
-0.3% -$5.72K 0.42% 52
2015
Q1
$1.7M Buy
14,767
+1,926
+15% +$230K 0.41% 54
2014
Q4
$9.51K Buy
12,841
+4,645
+57% +$490K 0.2% 105
2014
Q3
$777K Sell
8,196
-10,940
-57% -$987K 0.2% 133
2014
Q2
$800K Buy
19,136
+11,370
+146% +$865K 0.19% 117
2014
Q1
$542K Buy
7,766
+3,202
+70% +$254K 0.16% 141
2013
Q4
$386K Buy
4,564
+126
+3% +$9.97K 0.12% 188
2013
Q3
$342K Buy
4,438
+230
+5% +$16.1K 0.12% 200
2013
Q2
$246K Buy
+4,208
New +$253K 0.08% 273

Other funds holding CELG

B. Riley Wealth Advisors's CELG Position: Q4 2019 in Review

B. Riley Wealth Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 16,727 shares — an estimated $1.66M sold.

B. Riley Wealth Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.84M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • B. Riley Wealth Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 16,727 Celgene Corp shares in Q4 2019, an estimated $1.66M.
  • B. Riley Wealth Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • B. Riley Wealth Advisors's Celgene Corp position peaked at $2.84M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2019, filed 10 Feb 2020.